{"denoms":[{"counts":[{"groupId":"BG000","value":"40"}],"units":"Participants"}],"groups":[{"description":"Donor lymphocyte preparation depleted of host functional alloreactive T-cells: Single intravenous infusion with 2x10E6 T-cells/kg","id":"BG000","title":"ATIR"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"19","upperLimit":"65","value":"45"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"16"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"24"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"1"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"2"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"36"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"5"}],"title":"Acute lymphatic leukemia"},{"measurements":[{"groupId":"BG000","value":"22"}],"title":"Acute myeloid leukemia"},{"measurements":[{"groupId":"BG000","value":"1"}],"title":"Chronic myeloid leukemia"},{"measurements":[{"groupId":"BG000","value":"3"}],"title":"Myelodysplastic syndrome"},{"measurements":[{"groupId":"BG000","value":"1"}],"title":"Myeloproliferative syndrome"},{"measurements":[{"groupId":"BG000","value":"2"}],"title":"Other acute leukemia"},{"measurements":[{"groupId":"BG000","value":"3"}],"title":"Other leukemia"},{"measurements":[{"groupId":"BG000","value":"3"}],"title":"Plasma cell disorder"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Hematologic malignancy","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"27"}],"title":"Donor HLA compatibility (HLA-A, -B, -DR): 3/6"},{"measurements":[{"groupId":"BG000","value":"13"}],"title":"Donor HLA compatibility (HLA-A, -B, -DR): 4/6"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Donor HLA compatibility (HLA-A, -B, -DR)","unitOfMeasure":"Participants"}]}